Ana I. Hughes
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study.
Journal: The Journal of pediatrics
Published: April 29, 2025
Erratum: Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 23, 2025
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 14, 2025
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.
Journal: Health technology assessment (Winchester, England)
Published: September 09, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Journal: The Lancet. Rheumatology
Published: November 16, 2023
Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action.
Journal: BMJ oncology
Published: May 25, 2023
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.
Journal: British journal of cancer
Published: January 26, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Journal: Nature medicine
Published: August 05, 2022
Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
Journal: European urology
Published: November 05, 2020
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial.
Journal: Pilot and feasibility studies
Published: August 13, 2019
The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma.
Journal: British journal of cancer
Published: July 07, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026